scispace - formally typeset
Journal ArticleDOI

Detection and sequence of mutations in the factor VIII gene of haemophiliacs

TLDR
The present work elucidates the molecular genetic basis of haemophilia in some individuals using the recently cloned factor VIII gene as a probe, and identifies two different nonsense point mutations in the factor VII gene of haenophiliacs, as well as two different partial deletions of the gene.
Abstract
The most common inherited bleeding disorder in man, haemophilia A, is caused by defect in factor VIII, a component in the blood coagulation pathway. The X-chromosome-linked disease almost certainly stems from a heterogeneous collection of genetic lesions. Because, without proper treatment, haemophilia can be a fatal disease, new mutations are necessary to account for its constant frequency in the population. In addition, haemophilia A displays a wide range of severity, and some 15% of haemophiliacs generate high levels of antibodies against factor VIII ('inhibitor patients'). The present work elucidates the molecular genetic basis of haemophilia in some individuals. Using the recently cloned factor VIII gene as a probe, we have identified two different nonsense point mutations in the factor VIII gene of haemophiliacs, as well as two different partial deletions of the gene. Our survey of 92 haemophiliacs indicates no firm correlation between antibody (inhibitor) production and gross gene defects.

read more

Citations
More filters
Journal ArticleDOI

The molecular basis of blood coagulation

TL;DR: This work focuses on the molecular basis of blood coagulation with particular attention to the biochemistry and regulation of this pathway as it relates to humans in health and disease.
Journal ArticleDOI

The hemophilias--from royal genes to gene therapy.

TL;DR: Of the various types of hemophilia, the most common of these lifelong bleeding disorders are due to an inherited deficiency of factor VIII or factor IX (Table 1).
Journal ArticleDOI

The CpG dinucleotide and human genetic disease

TL;DR: Findings are consistent with methylation-induced deamination of 5-methyl cytosine and suggest that methylation of DNA within coding regions may contribute significantly to the incidence of human genetic disease.
Journal ArticleDOI

Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man.

TL;DR: The results indicate that certain L1 sequences in man can be dispersed, presumably by an RNA intermediate, and cause disease by insertional mutation.
Journal ArticleDOI

An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.

TL;DR: By means of this method, carrier detection and prenatal diagnosis of hemophilia in two families are performed with use of the factor VIII intragenic polymorphisms identified by the restriction enzymes Bc/I and XbaI.
References
More filters
Journal ArticleDOI

Organization and Expression of Eucaryotic Split Genes Coding for Proteins

TL;DR: This paper organizes the organization of protein codes into split genes, a small number of which are expressed in the chickenuct, and discusses generalization, generalization and Molecular Evolution.

Expression of eucaryotic split genes coding for proteins

TL;DR: In this paper, the split genes were described as follows: Globin genes expressed in the chicken o,iduct, Vitellogenin genes, Collagen genes and Actin genes.
Journal ArticleDOI

Characterization of the human factor VIII gene

TL;DR: The complete 186,000 base-pair (bp) human factor VIII gene has been isolated and consists of 26 exons ranging in size from 69 to 3,106 bp and introns as large as 32.4 kilobases as mentioned in this paper.
Journal ArticleDOI

Structure of human factor VIII.

TL;DR: Determination of the thrombin cleavage sites in plasma-derived factor VIII polypeptides allows prediction of the domains involved in the associated activation and inactivation of the protein.
Journal ArticleDOI

Expression of active human factor VIII from recombinant DNA clones

TL;DR: The recombinant protein corrects the clotting time of plasma from haemophiliacs and has many of the biochemical and immunological characteristics of serum-derived factor VIII.
Related Papers (5)